Chugai Files Approval Application for Enspryng in...
Category : Product Related Updates 3 August 2026Chugai Seeks New Indication for Enspryng Chugai Pharmaceutical Co., Ltd. has announced that it ha...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Atavistik Bio Joins Cure HHT Clinical Trial Networ...
Category : Clinical Trial Update 3 August 2026Atavistik Bio Expands HHT Clinical Development Efforts Atavistik Bio has announced that it has jo...
MannKind Reports Positive Phase 1b Results for Inh...
Category : Clinical Trial Update 31 July 2026Study Shows Favorable Safety Profile for Inhaled Nintedanib in IPF Patients MannKind Corporation...
Kaigene Licenses Autoimmune Drug Candidate KG006 t...
Category : Licensing/Collaboration Deal 31 July 2026Partnership Aims to Expand Autoimmune Treatment Development in Japan Kaigene, Inc., a biotechnolo...
ViiV Healthcare Shares New HIV Treatment and Preve...
Category : Clinical Trial Update 31 July 2026New Studies Highlight Progress in Long-Acting HIV Care GSK plc announced that ViiV Healthcare pre...
Latest Newsletter Post
-
Atavistik Bio Joins Cure HHT Clinic..
3 August 2026
-
Chugai Files Approval Application f..
3 August 2026
-
ViiV Healthcare Shares New HIV Trea..
31 July 2026
-
Kaigene Licenses Autoimmune Drug Ca..
31 July 2026
-
MannKind Reports Positive Phase 1b..
31 July 2026
